Benzinga
Benzinga Pro
Marketfy
Financial Data & APIs
Fintech Awards
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Username:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
'
Looking for
?
CLICK HERE
Contribute
Login
Sign up
Benzinga - Feed Your Mind.
Home
Best of Benzinga
Careers
About
Contact Us
Partners
Benzinga Fintech Awards
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Markets
Pre-Market
After Hours
Movers
Forex
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
ETFs
Tech
Start-Ups
Fintech
Personal Finance
Marketfy
Benzinga Pro
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
Anheuser-Busch InBev (NYSE:BUD) Wall Street Journal
More From BUD
Summary
Ideas
Twitter ($BUD)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Benzinga Professional
Subscribe
5:01 PM
UBS asks "Where is value in G10 FX?" Says "EUR looks quite cheap ..." via ForexLive
4:57 PM
Bristol-Myers Squibb Company Announces Four-Year Follow-up with Empliciti Plus Lenalidomide/Dexamethasone in Patients with Advanced Multiple Myeloma Shows Long-term Efficacy in ELOQUENT-2 Trial #EHA2017
4:55 PM
Agios Pharma Announces New Data from Phase 1/2 Trial of Oral IDHIFA Demonstrate Durable Complete Responses in Patients with IDH2 Mutant Relapsed or Refractory AML #EHA2017
04:54 PM
Agios Pharma Announces Updated Data from Fully Enrolled DRIVE PK Study Demonstrating AG-348's Potential as First Disease-modifying Treatment for Patients with PKR #EHA2017
4:52 PM
Intrawest Announces HSR Waiting Period Expiration for Proposed Acquisition
04:07 PM
Amazon Names The 20 Best Books Of 2017; Did Your Favorite Make The List?
04:03 PM
Barron's Picks And Pans: Canadian Stocks, NCR, Gilead And More
03:55 PM
6 Part-Time Summer Jobs To Boost Your Bank Account
09:51 AM
Kevin Kelly's Bullish Health Care ETF Trade
09:47 AM
Bob Seger Finally Joined The Streaming World: Here Are 8 Music Icons Still Holding Out
09:42 AM
Breaking Up The Boys Club: Mish Schneider Talks Trading Floor Culture, The Market's 'Modern Family'
09:39 AM
Uber Was Being Run As A 'Frat Party,' Former GM Exec Says
09:26 AM
Pete Najarian Sees Unusual Options Activity In ArcelorMittal
9:01 AM
The Saudi 13-part ultimatum to Qatar is insane via ForexLive
5:26 PM
Reminder: Global Blood Therapeutics Expected To Present Prelim. Data On GBT440 At EHA Tomorrow 6.24.17
Trending
Recent
1
LPL, AGTC
: 20 Stocks Moving In Friday's Pre-Market Session
2
PTLA
: Citi Says Expect FDA PDUFA Decision For Portola Pharma Early
3
OCUL, SKT
: Benzinga's Top Upgrades, Downgrades For June 23, 2017
4
PTLA
: Portola Receives FDA Approval For Bevyxxa
5
BBBY, BBRY
: 5 Stocks To Watch For June 23, 2017
6
BLCM
: Despite A Volatile Trading Week, Bellicu...
7
NTLA, ALNY
: 6 Biotech Stocks Jefferies Say...
1
AGIO
: Agios Pharma Announces Updated Data from Fully Enrolled DRIVE PK Study Demon...
2
AMZN
: Amazon Names The 20 Best Books Of 2017; Did Your Favorite Make The List?
3
GILD, AIZ
: Barron's Picks And Pans: Canadian Stocks, NCR, Gilead And More
4
6 Part-Time Summer Jobs To Boost Your Bank Account
5
XLV
: Kevin Kelly's Bullish Health Care ETF Trade
6
AAPL, P
: Bob Seger Finally Joined The Streaming World: Here Ar...
7
IBB, IWM
: Breaking Up The Boys Club: Mish Schneider Tal...